Back to results
CompletedPhase 3

Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease

NCT04994483

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

MDFirst Research

Chandler, Arizona, United States

+87 additional locations

View on ClinicalTrials.gov
Simufilam 100 mg for Mild-to-Moderate Alzheimer's Disease — TrialFind